Some insurers raise drug prices after enrollment
USA Today - Researchers tracked the changes among plans in five states in five drugs: blood pressure drug Altace; pain-killer Celebrex; cholesterol drug Lipitor; angina drug Nifedipine ER; and depression treatment Zoloft. Costs include co-payments and prices
Source: www.usatoday.com
Industry Wrapups
Houston Business Journal - Buffalo's stampedes into Texas market with Houston eatery [Thursday] National Office Partners divests properties [Thursday] Imperial Sugar names new CFO [Thursday] Greater Houston Partnership president resigns [Thursday] Cyberonics' depression-treatment
Source: houston.bizjournals.com
FDA Approves AstraZeneca's SEROQUEL(R) For Bipolar Depression
Yahoo Finance - -- SEROQUEL is now the first and only single medication approved by the FDA to treat both depressive and manic episodes associated with bipolar disorder -- WILMINGTON, Del., Oct. 20 /PRNewswire-FirstCall/ -- AstraZeneca (NYSE: AZN - News ) today
Source: biz.yahoo.com
Anti-Depressant Safe & Effective for Children
WANE-TV - She and researchers from seven other institutions, including the drug's maker, Pfizer, performed a depression treatment study of nearly 400 children, ages six to 17. These children had all suffered from depression for an average of nearly two years
Source: www.wane.com
On the blog now:
Town Hall - Recent months have been eventful and largely rough for Cyberonics Inc., including news the medical-device company is unlikely to win Medicare reimbursement approval for its depression-treatment system. That follows Duke Balancing Demand Vs. Global
Source: www.townhall.com
Click here for more information about seasonal depression seasonal depression
<< Home